Connection

Katharine Floyd to Antibodies, Neutralizing

Back to Details
This is a "connection" page, showing publications Katharine Floyd has written about Antibodies, Neutralizing.
Katharine Floyd
Connection Strength
0.280
Antibodies, Neutralizing
  1. Durability of mRNA-1273 vaccine-induced antibodies against SARS-CoV-2 variants. Science. 2021 09 17; 373(6561):1372-1377.
    View in: PubMed
    Score: 0.034
  2. Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants. N Engl J Med. 2021 08 12; 385(7):664-666.
    View in: PubMed
    Score: 0.034
  3. Isolation and characterization of cross-neutralizing coronavirus antibodies from COVID-19+ subjects. Cell Rep. 2021 07 13; 36(2):109353.
    View in: PubMed
    Score: 0.033
  4. Infection- and vaccine-induced antibody binding and neutralization of the B.1.351 SARS-CoV-2 variant. Cell Host Microbe. 2021 04 14; 29(4):516-521.e3.
    View in: PubMed
    Score: 0.033
  5. Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India. Virology. 2021 06; 558:13-21.
    View in: PubMed
    Score: 0.033
  6. Durability of Responses after SARS-CoV-2 mRNA-1273 Vaccination. N Engl J Med. 2021 01 07; 384(1):80-82.
    View in: PubMed
    Score: 0.032
  7. Development of a Rapid Focus Reduction Neutralization Test Assay for Measuring SARS-CoV-2 Neutralizing Antibodies. Curr Protoc Immunol. 2020 12; 131(1):e116.
    View in: PubMed
    Score: 0.032
  8. Protective antibodies elicited by SARS-CoV-2 spike protein vaccination are boosted in the lung after challenge in nonhuman primates. Sci Transl Med. 2021 08 18; 13(607).
    View in: PubMed
    Score: 0.008
  9. A yeast expressed RBD-based SARS-CoV-2 vaccine formulated with 3M-052-alum adjuvant promotes protective efficacy in non-human primates. Sci Immunol. 2021 07 15; 6(61).
    View in: PubMed
    Score: 0.008
  10. SARS-CoV-2 RBD trimer protein adjuvanted with Alum-3M-052 protects from SARS-CoV-2 infection and immune pathology in the lung. Nat Commun. 2021 06 11; 12(1):3587.
    View in: PubMed
    Score: 0.008
  11. Antibody Persistence through 6 Months after the Second Dose of mRNA-1273 Vaccine for Covid-19. N Engl J Med. 2021 06 10; 384(23):2259-2261.
    View in: PubMed
    Score: 0.008
  12. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs. Immunity. 2021 03 09; 54(3):542-556.e9.
    View in: PubMed
    Score: 0.008
  13. Safety and Immunogenicity of SARS-CoV-2 mRNA-1273 Vaccine in Older Adults. N Engl J Med. 2020 12 17; 383(25):2427-2438.
    View in: PubMed
    Score: 0.008
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.